Novonesis (Novozymes) A/S Financial Flexibility Index
Novonesis (Novozymes) A/S financial flexibility index. Novonesis (Novozymes) A/S (NSIS-B) has a Financial Flexibility Index of 0.04x as of March 2026. Free cash flow of Dkr246.14 Million (operating CF Dkr167.06 Million minus capex Dkr79.08 Million) represents 0% of total liabilities (Dkr5.60 Billion). Explore Novonesis (Novozymes) A/S (NSIS-B) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Novonesis (Novozymes) A/S (2002–2025)
Financial flexibility index of Novonesis (Novozymes) A/S from 2002 to 2025. Historical Financial Flexibility Index trend for Novonesis (Novozymes) A/S across 24 annual periods. Check Novonesis (Novozymes) A/S (NSIS-B) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Novonesis (Novozymes) A/S Financial Flexibility Index by Year (2002–2025)
Novonesis (Novozymes) A/S financial flexibility index by year from 2002 to 2025. Year-by-year free cash flow to debt coverage for Novonesis (Novozymes) A/S. For the full cash flow conversion analysis, see cash flow conversion of Novonesis (Novozymes) A/S.
| Year | Flexibility Index | Free Cash Flow (DKK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | Dkr1.69 Billion | Dkr1.22 Billion | Dkr5.49 Billion | ▼ -10.3% |
| 2024 | 0.34x | Dkr1.38 Billion | Dkr1.02 Billion | Dkr4.02 Billion | ▼ -22.4% |
| 2023 | 0.44x | Dkr6.21 Billion | Dkr4.15 Billion | Dkr14.04 Billion | ▼ -11.8% |
| 2022 | 0.50x | Dkr6.90 Billion | Dkr4.01 Billion | Dkr13.76 Billion | ▲ +18.8% |
| 2021 | 0.42x | Dkr5.30 Billion | Dkr4.06 Billion | Dkr12.56 Billion | ▼ -26.1% |
| 2020 | 0.57x | Dkr5.29 Billion | Dkr4.36 Billion | Dkr9.27 Billion | ▲ +26.1% |
| 2019 | 0.45x | Dkr4.06 Billion | Dkr3.20 Billion | Dkr8.96 Billion | ▼ -25.3% |
| 2018 | 0.61x | Dkr5.01 Billion | Dkr3.68 Billion | Dkr8.26 Billion | ▼ -23.8% |
| 2017 | 0.80x | Dkr5.66 Billion | Dkr4.06 Billion | Dkr7.11 Billion | ▲ +11.9% |
| 2016 | 0.71x | Dkr4.92 Billion | Dkr3.84 Billion | Dkr6.91 Billion | ▲ +2.3% |
| 2015 | 0.69x | Dkr4.31 Billion | Dkr3.34 Billion | Dkr6.20 Billion | ▼ -5.0% |
| 2014 | 0.73x | Dkr5.23 Billion | Dkr4.53 Billion | Dkr7.15 Billion | ▲ +18.4% |
| 2013 | 0.62x | Dkr3.36 Billion | Dkr2.60 Billion | Dkr5.44 Billion | ▼ -13.0% |
| 2012 | 0.71x | Dkr3.94 Billion | Dkr2.76 Billion | Dkr5.54 Billion | ▼ -11.6% |
| 2011 | 0.80x | Dkr4.03 Billion | Dkr2.71 Billion | Dkr5.02 Billion | ▲ +4.7% |
| 2010 | 0.77x | Dkr3.65 Billion | Dkr2.32 Billion | Dkr4.76 Billion | ▲ +36.4% |
| 2009 | 0.56x | Dkr2.84 Billion | Dkr1.82 Billion | Dkr5.04 Billion | ▲ +15.5% |
| 2008 | 0.49x | Dkr2.66 Billion | Dkr1.70 Billion | Dkr5.45 Billion | ▲ +3.2% |
| 2007 | 0.47x | Dkr2.46 Billion | Dkr1.71 Billion | Dkr5.20 Billion | ▲ +5.9% |
| 2006 | 0.45x | Dkr2.04 Billion | Dkr1.53 Billion | Dkr4.57 Billion | ▼ -7.4% |
| 2005 | 0.48x | Dkr1.69 Billion | Dkr1.33 Billion | Dkr3.52 Billion | ▼ -3.8% |
| 2004 | 0.50x | Dkr1.62 Billion | Dkr1.29 Billion | Dkr3.24 Billion | ▼ -2.4% |
| 2003 | 0.51x | Dkr1.77 Billion | Dkr1.37 Billion | Dkr3.46 Billion | ▲ +35.8% |
| 2002 | 0.38x | Dkr1.55 Billion | Dkr1.18 Billion | Dkr4.10 Billion | — |